Bingyu Chen

Healthcare

+852 3767 1346

Vote Here

Bingyu Chen joined in April 2026, bringing 12+ years of experience across healthcare research, investing and IR, incl. Zai Lab, UBS AM and Citigroup’s No. 1-ranked Asia Healthcare team. Hongda Zhong joined in October 2025. Prior to joining Jefferies, he spent five years at Goldman Sachs covering the China healthcare sector.

What We Are Known For

Thought leadership. Leading the Asia healthcare conversation through differentiated research, proprietary insights and unparalleled industry access.

Investor Pulse. Deep engagement with investors, management teams and industry leaders enables early identification of emerging themes and market inflection points.

Differentiated Corporate Access. Connecting investors with the region’s most influential healthcare companies and direct access to industry participants through marquee events.

Independent & High Conviction. Known for challenging consensus and identifying the key inflection points shaping healthcare investment outcomes.